CLDX icon

Celldex Therapeutics
CLDX

Overview Fund Activity

180 hedge funds and large institutions have $1.48B invested in Celldex Therapeutics in 2025 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 75 increasing their positions, 42 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
180
Holders Change
+9
Holders Change %
+5.26%
% of All Funds
2.41%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
38
Increased
75
Reduced
42
Closed
28
Calls
$3.21M
Puts
$5.37M
Net Calls
-$2.16M
Net Calls Change
+$1.83M

Top Buyers

1
VPC
Vestal Point Capital
New York
$35.6M
2
LGM
Logos Global Management
California
$12.2M
3
BBA
Baker Bros. Advisors
New York
$13.5M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
$77.7M
5
SBH
Segall Bryant & Hamill
Illinois
$7.89M

Top Sellers

1
Wellington Management Group
Wellington Management Group
Massachusetts
$106M
2
EAM
Eventide Asset Management
Massachusetts
$27.6M
3
UBS Group
UBS Group
Switzerland
$17.1M
4
State Street
State Street
Massachusetts
$49M
5
KCM
Kynam Capital Management
New Jersey
$124M
Name Holding Trade Value Shares
Change 		Shares
Change %
SO
201
Sierra Ocean
California
– -$1.67K -92 Closed
Amundi
202
Amundi
France
– -$772 -45 Closed
HFS
203
Hughes Financial Services
Virginia
– -$404 -24 Closed
BTI
204
Blue Trust Inc
Georgia
– -$417 -23 Closed
SC
205
Stephens Consulting
Michigan
– -$363 -20 Closed
CCM
206
Coldstream Capital Management
Washington
– -$218 -12 Closed
5 6 7 8
9